Who
Hugh M. Davis
President and COO
Company insider
Files Form 4 as: President and COO, Aclaris Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Dec 2024
- Last trade
- 3 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 5 Feb 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code M | —18,675 | filing |
| 3 Feb 2026filed 5 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,675 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —18,675 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code M | —18,675 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,100 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —336,300 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,100 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —336,300 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,750 at $0.00 | filing |
| 2 Dec 2025filed 4 Dec 2025 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code M | —26,750 | filing |
| 3 Feb 2025filed 4 Feb 2025 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —74,700 at $0.00 | filing |
| 3 Feb 2025filed 4 Feb 2025 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —261,600 at $0.00 | filing |
| 2 Dec 2024filed 3 Dec 2024 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —375,000 at $0.00 | filing |
| 2 Dec 2024filed 3 Dec 2024 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.